Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteria.


Journal

Annals of the rheumatic diseases
ISSN: 1468-2060
Titre abrégé: Ann Rheum Dis
Pays: England
ID NLM: 0372355

Informations de publication

Date de publication:
07 2020
Historique:
received: 25 02 2020
revised: 19 04 2020
accepted: 21 04 2020
pubmed: 7 5 2020
medline: 10 7 2020
entrez: 7 5 2020
Statut: ppublish

Résumé

The Assessment of SpondyloArthritis international Society (ASAS) MRI working group conducted a multireader exercise on MRI scans from the ASAS classification cohort to assess the spectrum and evolution of lesions in the sacroiliac joint and impact of discrepancies with local readers on numbers of patients classified as axial spondyloarthritis (axSpA). Seven readers assessed baseline scans from 278 cases and 8 readers assessed baseline and follow-up scans from 107 cases. Agreement for detection of MRI lesions between central and local readers was assessed descriptively and by the kappa statistic. We calculated the number of patients classified as axSpA by the ASAS criteria after replacing local detection of active lesions by central readers and replacing local reader radiographic sacroiliitis by central reader structural lesions on MRI. Structural lesions, especially erosions, were as frequent as active lesions (≈40%), the majority of patients having both types of lesions. The ASAS definitions for active MRI lesion typical of axSpA and erosion were comparatively discriminatory between axSpA and non-axSpA. Local reader overcall for active MRI lesions was about 30% but this had a minor impact on the number of patients (6.4%) classified as axSpA. Substitution of radiography with MRI structural lesions also had little impact on classification status (1.4%). Despite substantial discrepancy between central and local readers in interpretation of both types of MRI lesion, this had a minor impact on the numbers of patients classified as axSpA supporting the robustness of the ASAS criteria for differences in assessment of imaging.

Identifiants

pubmed: 32371388
pii: annrheumdis-2020-217232
doi: 10.1136/annrheumdis-2020-217232
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

935-942

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Walter P Maksymowych (WP)

Medicine, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada walter.maksymowych@ualberta.ca.

Susanne Juhl Pedersen (SJ)

Department of Rheumatology, Copenhagen University Hospital Glostrup, Glostrup, Denmark.

Ulrich Weber (U)

Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark, Sønderborg, Denmark.
Regional Health Research, University of Southern Denmark, Odense, Denmark.

Xenofon Baraliakos (X)

Rheumazentrum Ruhrgebiet, Herne, Germany.

Pedro M Machado (PM)

MRC Centre for Neuromuscular Diseases, University College London, London, UK.
Rheumatology, University College London Centre for Rheumatology, London, UK.

Iris Eshed (I)

Radiology, Sheba Medical Center, Tel Hashomer, Israel.

Manouk de Hooge (M)

VIB Center of Inflammation Research, Ghent University, Gent, Belgium.

Joachim Sieper (J)

Medical Department I, Rheumatology, University Clinic Benjamin Franklin, Berlin, Germany.

Stephanie Wichuk (S)

Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Martin Rudwaleit (M)

Internal Medicine and Rheumatology, Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany.

Désirée van der Heijde (D)

Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Rheumatology, Diakonhjemmet Hospital, Norway.

Robert B M Landewé (RBM)

Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands.
Rheumatology, Zuyderland MC, Heerlen, The Netherlands.

Denis Poddubnyy (D)

Department of Rheumatology, Infectious Diseases and Rheumatology, Charité Universitätsmedizin Berlin, Berlin, Germany.

Mikkel Ostergaard (M)

Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup, Glostrup, Denmark.

Robert G W Lambert (RGW)

Radiology and Diagnostic Imaging and Medical Imaging Consultants, University of Alberta, Edmonton, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH